Skip to content
Roboearth – Lifestyle
Author:
BERRY & COMPANY PUBLIC RELATIONS
Solu Therapeutics Granted FDA Fast Track Designation for STX-0712 for Treatment of Chronic Myelomonocytic Leukemia
May 27, 2026
GRIN Therapeutics’ Pivotal Phase 3 Beeline Study Initiated in Europe
May 4, 2026